PeptideFactSheetsAn independent reference
Menu

Botanical extract mixture · Fact sheet

Bacopa monnieri

Also known as Bacopa · Brahmi

Bacopa monnieri is a botanical extract studied for memory. Several small controlled trials found benefits on selected recall measures after weeks of treatment, with gastrointestinal adverse effects and limited evidence for broad cognitive enhancement.

Not FDA approvedModerate human evidence
Brain, mood & sleep

What is Bacopa monnieri?

Bacopa is a mixture of plant constituents rather than one peptide or purified chemical.

Brahmi is also used for other plants in some contexts; botanical identity and extract standardization matter.

Benefits & claims

Interest in Bacopa monnieri spans cognition and sleep. Study findings apply to the named formulation and population.

What the evidence supports

  • The 54-person trial found delayed-recall and Stroop effects after 12 weeks.
  • The 98-person trial found verbal-memory benefits but not significant differences on several other measures.
  • Results for standardized extracts cannot establish equivalent effects from every bacopa product.
Research areas
  • Formulation-specific human outcomes
  • Mechanistic research

Dosage & frequency

Human study context

This is an exposure from a named human study, not a generally established treatment or enhancement regimen.

Standardized bacopa older-adult trial

54 adults aged at least 65 without clinical dementia

Amount
300 mg standardized whole-plant dry extract
Frequency
Daily for 12 weeks after a six-week placebo run-in
Route studied or labeled
Oral

This is extract mass, not purified bacosides or an interchangeable amount of another botanical product. Effects were task-specific.

Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Brahmi is also used for other plants in some contexts; botanical identity and extract standardization matter.

Interactions & precautions

  • The reviewed sources do not establish a comprehensive human interaction profile for this exact substance or combination.

What is still unresolved

  • Reproducibility in larger independent trials
  • Long-term outcomes and adverse effects
  • Equivalence of different preparations and interaction profiles
Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. FDA: what approval means for supplements

Side effects & risks

  • Trials reported stomach upset, increased stool frequency, abdominal cramps and nausea.
  • Long-term interactions and safety in pregnancy or complex neurologic disease were not established by these trials.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Moderate human evidence

Controlled trials in older adults found better verbal learning or delayed recall, but not every cognitive test or subjective memory measure improved.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 2 sourced accounts by reported effect.

Energy: reported experiences

Mixed account · personal report

Less anxiety and deeper sleep, but emotional flatness

An author described less anxiety and deeper sleep, alongside apathy, less enjoyment of social activities and difficulty waking. An edit said they noticed no memory or cognitive benefit; a later edit described fewer negatives after changing their amount.

Reported use in this account

Product
Bacopa extracts; switched formulations
Amount
Not specified clearly
Frequency
Daily
Route
Not specified clearly
Duration
About two months on the first extract, followed by another extract

Other exposures described: Occasional phenibut; Alcohol; Coffee

The author changed between extracts and also described occasional phenibut, alcohol and coffee. Tablet strength and a clear total exposure duration were not given. The extracts cannot be treated as interchangeable.

Read the original account
Negative account · personal report

Irritability, lethargy and feeling detached

Another author described irritability, fatigue, feeling detached and marked loss of motivation after first trying a Synapsa bacopa extract. They said they felt better after discontinuation.

Amount, frequency, route and duration could not be confirmed for this account.

The author already had trauma-related emotional symptoms and mentioned recent microdosing without identifying the substance. These concurrent factors prevent a clean causal interpretation.

Read the original account

Approval status

No FDA-approved Bacopa monnieri drug indication is established for the supplement uses discussed here. Supplement availability is not FDA approval of efficacy or safety.

No FDA-approved product for this entry

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Reproducibility in larger independent trials
  • Long-term outcomes and adverse effects
  • Equivalence of different preparations and interaction profiles

Summary

Results for standardized extracts cannot establish equivalent effects from every bacopa product.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  3. fdaFDA: what approval means for supplements

    Dietary supplements are not approved by FDA for safety and effectiveness before marketing.

How we assess sources · Suggest a correction